Back to Search
Start Over
FDA's renewed focus on oncology dosing spooks investors, but companies say they're ready
- Source :
- Fiercebiotech.com. June 28, 2021
- Publication Year :
- 2021
-
Abstract
- Byline: Annalee Armstrong When it comes to dosing in oncology clinical trials, the FDA thinks less is more. The agency is launching Project Optimus from the FDA's Oncology Center of [...]
- Subjects :
- Pharmaceutical industry
Biotechnology industry
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Fiercebiotech.com
- Publication Type :
- News
- Accession number :
- edsgcl.666688448